SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Aug-24 6:34 PM View: | Genelux Corp (GNLX) | 01-Aug-24 | Grant | 39,541 | -- | -- | 300% 13.17K to 52.71K | |
07-Jun-24 9:45 PM View: | Genelux Corp (GNLX) | 29-May-24 | Purchase | 6,250 | -- | -- | 90% 6.92K to 13.17K | |
15-Feb-24 6:23 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 13-Feb-24 | Grant | 11,365 | -- | -- | 8% 141.39K to 152.76K | |
14-Sep-23 8:18 PM View: | Genelux Corp (GNLX) | 13-Sep-23 | Private Sale | 900 | $20.78 | $18,702.00 | (12%) 7.82K to 6.92K | |
13-Sep-23 8:14 PM View: | Genelux Corp (GNLX) | 11-Sep-23 | Grant | 6,920 | -- | -- | 769% 0.9K to 7.82K | |
27-Aug-21 6:26 PM View: | Effector Therapeutics, Inc. (EFTR) | 25-Aug-21 | Grant | 24,142 | -- | -- | 100% 0 to 24.14K | |
11-Mar-21 3:59 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Mar-21 | Option Exercise | 500 | $1.68 | $840.30 | < 1% 134.29K to 134.79K | |
11-Mar-21 3:59 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Mar-21 | Market Option Sale (Planned) | 500 | $32.90 | $16,450.00 | (< 1%) 134.79K to 134.29K | |
11-Mar-21 3:59 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Mar-21 | Market Sale (Planned) | 1,250 | $32.90 | $41,125.00 | (< 1%) 134.29K to 133.04K | |
05-Mar-21 3:55 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Mar-21 | Option Exercise | 12,396 | $1.68 | $20,832.70 | 10% 121.89K to 134.29K | |
05-Mar-21 3:55 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 03-Mar-21 | Grant | 9,500 | -- | -- | 8% 112.39K to 121.89K | |
03-Mar-21 4:48 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Mar-21 | Market Sale (Planned) | 773 | $34.20 | $26,439.70 | (< 1%) 113.16K to 112.39K | < 1% |
12-Feb-21 5:32 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Feb-21 | Option Exercise | 750 | $1.68 | $1,260.45 | < 1% 115.16K to 115.91K | |
12-Feb-21 5:32 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Feb-21 | Market Option Sale (Planned) | 750 | $35.64 | $26,730.00 | (< 1%) 115.91K to 115.16K | |
12-Feb-21 5:32 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 10-Feb-21 | Market Sale (Planned) | 2,000 | $35.64 | $71,280.00 | (2%) 115.16K to 113.16K | |
03-Feb-21 11:23 AM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Feb-21 | Option Exercise | 1,250 | $1.68 | $2,100.75 | 1% 118.91K to 120.16K | |
03-Feb-21 11:23 AM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Feb-21 | Market Option Sale (Planned) | 1,250 | $35.00 | $43,750.00 | (1%) 120.16K to 118.91K | |
03-Feb-21 11:23 AM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 01-Feb-21 | Market Sale (Planned) | 3,750 | $35.00 | $131,250.00 | (3%) 118.91K to 115.16K | |
21-Jan-21 4:41 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 19-Jan-21 | Option Exercise | 500 | $1.68 | $840.30 | < 1% 120.16K to 120.66K | |
21-Jan-21 4:41 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 19-Jan-21 | Market Option Sale (Planned) | 500 | $30.00 | $15,000.00 | (< 1%) 120.66K to 120.16K | |
21-Jan-21 4:41 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 19-Jan-21 | Market Sale (Planned) | 1,250 | $30.00 | $37,500.00 | (1%) 120.16K to 118.91K | |
16-Dec-20 3:14 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Dec-20 | Option Exercise | 1,500 | $1.68 | $2,520.90 | 1% 123.91K to 125.41K | |
16-Dec-20 3:14 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Dec-20 | Planned Option Sale | 1,500 | $30.00 | $45,000.00 | (1%) 125.41K to 123.91K | |
16-Dec-20 3:14 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 14-Dec-20 | Sale (Planned) | 3,750 | $30.00 | $112,500.00 | (3%) 123.91K to 120.16K | |
01-Oct-20 9:00 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 29-Sep-20 | Option Exercise | 500 | $1.68 | $840.30 | < 1% 123.84K to 124.34K | |
01-Oct-20 9:00 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 29-Sep-20 | Planned Option Sale | 500 | $30.00 | $15,000.00 | (< 1%) 124.34K to 123.84K | |
01-Oct-20 9:00 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 29-Sep-20 | Sale (Planned) | 1,250 | $30.00 | $37,500.00 | (1%) 123.84K to 122.59K | |
15-Jun-20 3:15 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 11-Jun-20 | Option Exercise | 14,875 | $1.68 | $24,998.90 | 14% 108.97K to 123.84K | |
03-Mar-20 9:09 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 27-Feb-20 | Grant | 9,000 | -- | -- | 9% 99.97K to 108.97K | |
03-Jan-19 6:19 PM View: | Sienna Biopharmaceuticals, ... (SNNA) | 01-Jan-19 | Grant | 45,000 | -- | -- | 123% 36.62K to 81.62K | |
02-Oct-15 2:15 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 01-Oct-15 | Disposition | 17,960 | -- | -- | (74%) 24.18K to 6.22K | |
02-Oct-15 2:15 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 01-Oct-15 | Disposition | 6,216 | -- | -- | (100%) 6.22K to 0 | |
28-Sep-15 6:28 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 25-Sep-15 | Option Exercise | 14,017 | $4.84 | $67,842.30 | 146% 9.58K to 23.6K | |
24-Sep-15 9:38 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 24-Sep-15 | Option Exercise | 26,917 | $35.95 | $967,582.00 | 281% 9.58K to 36.5K | |
24-Sep-15 9:38 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 24-Sep-15 | Market Option Sale | 26,917 | $74.90 | $2,016,080.00 | (74%) 36.5K to 9.58K | (< 1%) |
24-Sep-15 9:38 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 23-Sep-15 | Option Exercise | 26,918 | $17.99 | $484,361.00 | 281% 9.58K to 36.5K | |
24-Sep-15 9:38 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 23-Sep-15 | Market Option Sale | 26,918 | $74.90 | $2,016,160.00 | (74%) 36.5K to 9.58K | (< 1%) |
23-Sep-15 6:00 AM View: | Kythera Biopharmaceuticals ... (KYTH) | 22-Sep-15 | Option Exercise | 5,591 | $8.22 | $45,958.00 | 58% 9.58K to 15.18K | |
23-Sep-15 6:00 AM View: | Kythera Biopharmaceuticals ... (KYTH) | 22-Sep-15 | Market Option Sale | 5,591 | $74.90 | $418,766.00 | (37%) 15.18K to 9.58K | < 1% |
23-Sep-15 6:00 AM View: | Kythera Biopharmaceuticals ... (KYTH) | 18-Sep-15 | Option Exercise | 1,054 | $8.22 | $8,663.88 | 11% 9.58K to 10.64K | |
23-Sep-15 6:00 AM View: | Kythera Biopharmaceuticals ... (KYTH) | 18-Sep-15 | Market Option Sale | 1,054 | $74.95 | $78,997.30 | (10%) 10.64K to 9.58K | < 1% |
23-Sep-15 6:00 AM View: | Kythera Biopharmaceuticals ... (KYTH) | 26-Jun-15 | Gift | 1,400 | -- | -- | (13%) 10.98K to 9.58K | |
25-Jun-15 6:33 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 25-Jun-15 | Market Sale | 4,600 | $75.50 | $347,300.00 | (30%) 15.58K to 10.98K | < 1% |
30-Apr-15 9:27 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 30-Apr-15 | Market Sale | 2,041 | $45.49 | $92,845.10 | (12%) 17.63K to 15.58K | (22%) |
30-Apr-15 9:27 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 29-Apr-15 | Grant | 5,409 | -- | -- | 44% 12.22K to 17.63K | |
05-Mar-15 6:19 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 05-Mar-15 | Market Sale (Planned) | 4,200 | $48.09 | $201,980.00 | (26%) 16.42K to 12.22K | (16%) |
19-Feb-15 6:43 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 18-Feb-15 | Market Sale (Planned) | 1,000 | $42.00 | $42,000.00 | (6%) 17.42K to 16.42K | (32%) |
19-Feb-15 6:43 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 17-Feb-15 | Market Sale (Planned) | 1,000 | $40.00 | $40,000.00 | (5%) 18.42K to 17.42K | (39%) |
02-Feb-15 4:26 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 29-Jan-15 | Market Sale (Planned) | 1,000 | $38.00 | $38,000.00 | (5%) 19.42K to 18.42K | (46%) |
27-Jan-15 5:54 PM View: | Kythera Biopharmaceuticals ... (KYTH) | 23-Jan-15 | Market Sale (Planned) | 3,000 | $35.65 | $106,940.00 | (13%) 22.42K to 19.42K | (56%) |